Abstract
The current study aims to determine the effectiveness of rational emotive behavioral therapy (REBT) base group therapy on anger and depression of patients with multiple sclerosis (MS). This randomized controlled trial study conducted with pre-test, post-test, and control group. Data was collected using the Beck depression inventory (BDI) and State-Trait Anger Expression Inventory 2 (STAXI-2). A total of 18 patients from the MS Society of Zahedan southeast of Iran participated in this study and randomly assigned to the intervention and control groups. The intervention group takes rational emotive behavioral therapy over 89-min sessions. The results of ANOVA repeated measures showed that rational emotive behavioral therapy has significantly reduced the depression of patients with multiple sclerosis (P < 0.05). However, the anger of these patients was not significantly reduced after treatment. The findings of this research indicate that REBT is not reducing the anger of patients with MS. These findings may be a guideline for experts to examine the other approaches for reducing the anger problem of these patients.
Similar content being viewed by others
References
Cox DE, Harrison DWJBS, Function. Models of anger: contributions from psychophysiology, neuropsychology and the cognitive behavioral perspective. Brain Struct Funct. 2008;212(5):371–85. https://doi.org/10.1007/s00429-007-0168-7.
David D, Lynn SJ, Ellis A. Rational and irrational beliefs: research, theory, and clinical practice. Oxford University Press; 2010.
David D, Cotet C, Matu S, Mogoase C, Stefan S. 50 years of rational-emotive and cognitive-behavioral therapy: a systematic review and meta-analysis. J Clin Psychol. 2018;74(3):304–18. https://doi.org/10.1002/jclp.22514.
Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la Cadena C. Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatr Clin Neurosci. 1999;11(1):51–7. https://doi.org/10.1176/jnp.11.1.51.
Fiest KM, Walker JR, Bernstein CN, Graff LA, Zarychanski R, Abou-Setta AM, et al. Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord. 2016;5:12–26. https://doi.org/10.1016/j.msard.2015.10.004.
Fischer A, Schroder J, Vettorazzi E, Wolf OT, Pottgen J, Lau S, et al. An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial. Lancet Psychiatry. 2015;2(3):217–23. https://doi.org/10.1016/S2215-0366(14)00049-2.
Forman A, Lincoln NJCR. Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin Rehabil. 2010;24(3):211–21.
Gottberg K, Chruzander C, Backenroth G, Johansson S, Ahlstrom G, Ytterberg C. Individual face-to-face cognitive behavioural therapy in multiple sclerosis: a qualitative study. J Clin Psychol. 2016;72(7):651–62. https://doi.org/10.1002/jclp.22288.
Hull L, Farrin L, Unwin C, Everitt B, Wykes T, David ASJP, et al. Anger, psychopathology and cognitive inhibition: a study of UK servicemen. Personal Individ Differ. 2003;35(5):1211–26.
Humphreys I, Drummond AE, Phillips C, Lincoln NB. Cost-effectiveness of an adjustment group for people with multiple sclerosis and low mood: a randomized trial. 2013;27(11):963–71. https://doi.org/10.1177/0269215513488608.
Janssens AC, Van Doorn P, De Boer J, Kalkers N, van der Meché FG, Passchier J, et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler. 2003;9(4):397–403.
Julian LJ, Vella L, Frankel D, Minden SL, Oksenberg JR, Mohr DC. ApoE alleles, depression and positive affect in multiple sclerosis. Mult Scler. 2009;15(3):311–5. https://doi.org/10.1177/1352458508099478.
Kiropoulos LA, Kilpatrick T, Holmes A, Threader J. A pilot randomized controlled trial of a tailored cognitive behavioural therapy based intervention for depressive symptoms in those newly diagnosed with multiple sclerosis. BMC Psychiatry. 2016;16(1):435. https://doi.org/10.1186/s12888-016-1152-7.
Koh KB, Kim CH, Park JK. Predominance of anger in depressive disorders compared with anxiety disorders and somatoform disorders. J Clin Psychiatry. 2002;63(6):486–92. https://doi.org/10.4088/jcp.v63n0604.
Lambert M. The effectiveness of psychotherapy. W: Bergin AE, Garfield SL, red. Handbook of psychotherapy and behaviour change. In: New York: Wiley; 1994.
Lima FS, Simioni S, Bruggimann L, Ruffieux C, Dudler J, Felley C, et al. Perceived behavioral changes in early multiple sclerosis. Behav Neurol. 2007;18(2):81–90.
Malcomson KS, Dunwoody L, Lowe-Strong AS. Psychosocial interventions in people with multiple sclerosis: a review. J Neurol. 2007;254(1):1–13. https://doi.org/10.1007/s00415-006-0349-y.
Mohr DC, Cox D. Multiple sclerosis: empirical literature for the clinical health psychologist. J Clin Psychol. 2001;57(4):479–99. https://doi.org/10.1002/jclp.1042.
Mohr DC, Goodkin DE. Treatment of Depression in Multiple Sclerosis: Review and Meta-analysis. Clinical Psychology: Science and Practice. 2006;6(1):1–9. https://doi.org/10.1093/clipsy.6.1.1.
Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol. 2001;69(6):942–9.
Ng LV, Khor KL. Anger experience and expression among adolescents: a test of the STAXI-2 C/A. Paper presented at the 3rd ASEAN Conference on Psychology, Counselling, and Humanities (ACPCH 2017). 2018.
Nocentini U, Tedeschi G, Migliaccio R, Dinacci D, Lavorgna L, Bonavita S, et al. An exploration of anger phenomenology in multiple sclerosis. Eur J Neurol. 2009;16(12):1312–7. https://doi.org/10.1111/j.1468-1331.2009.02727.x.
Patten SB, Metz LM, Reimer MA. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler. 2000;6(2):115–20. https://doi.org/10.1177/135245850000600210.
Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry. 2005;76(4):469–75. https://doi.org/10.1136/jnnp.2004.054635.
Solaro C, Gamberini G, Masuccio FG. Depression in multiple sclerosis: epidemiology, aetiology, diagnosis and treatment. CNS Drugs. 2018;32(2):117–33. https://doi.org/10.1007/s40263-018-0489-5.
Stevenson VL, Miller DH, Leary SM, Rovaris M, Barkhof F, Brochet B, et al. One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 2000;68(6):713–8. https://doi.org/10.1136/jnnp.68.6.713.
Whisman MA, Richardson EDJJ o CP. Normative data on the Beck Depression Inventory–second edition (BDI-II) in college students. J Clin Psychol. 2015;71(9):898–907.
Acknowledgements
The current study supported by the Zahedan University of Medical Science (ZAUMS).
Author information
Authors and Affiliations
Contributions
Homa Shahkaram performed the therapy, and Erfan Farhangian gathered the data. Shahab Lotfinia and Yazdan Madadjoo authored the article. Shahab Lotfinia, Yazdan Madadjoo, and Azizollah Mojahed provided the final review. The authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interests
The authors declare that they have no conflict of interests.
Ethics Approval and Consent to Participate
The Ethical Committee of ZAUMS reviewed and approved the study design and all procedures (IR.ZAUMS.REC.1396.29).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Medicine
Rights and permissions
About this article
Cite this article
Shahkaram, H., Lotfinia, S., Mojahed, A. et al. The Rational Emotive Behavioral Group Therapy for Depression and Anger of Patients with Multiple Sclerosis. SN Compr. Clin. Med. 2, 770–774 (2020). https://doi.org/10.1007/s42399-020-00331-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42399-020-00331-y